Radioactive Rx Study Regs Should Separate Pediatrics By Age – FDA Meeting
Executive Summary
Radioactive drug research committee study regulations should be changed to differentiate pediatric age groups, Columbia University Professor of Radiation Biophysics Eric Hall told FDA